D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
SLS holding history
SELLAS Life Sciences Group, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SLS overviewAll 13F holders of SLSFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −22,086−100.0% | Sold out | Holders |
| Q1 2022 | 22,086 | $148.0K | <0.1% | +2,943+15.4% | Added | Holders |
| Q4 2021 | 19,143 | $106.0K | <0.1% | −10,778−36.0% | Reduced | Holders |
| Q3 2021 | 29,921 | $274.0K | <0.1% | −2,193−6.8% | Reduced | Holders |
| Q2 2021 | 32,114 | $356.0K | <0.1% | +32,114 | New | Holders |